期刊文献+

CD40-siRNA慢病毒载体的构建及其对小鼠巨噬细胞的感染 被引量:1

Construction of siRNA Lentiviral Vector against CD40 and Measurement of Its Titer and Infection Efficiency on Mouse Macrophages Cells
下载PDF
导出
摘要 目的:构建CD40-siRNA慢病毒载体,检测其对小鼠巨噬细胞J774.1的感染效率及测定J774.1细胞的CD40 mRNA水平。方法:设计1段CD40的siRNA序列,构建慢病毒载体p LL3.7-CD40-siRNA,与p MD2.G、p MDLg/pRRE和pRSV-REV按比例采用Lipofectamine LTX&Plus共转染293T细胞制备病毒,感染J774.1细胞后第4、6和8天时用流式细胞仪检测其感染效率,实时荧光定量RT-PCR(qRT-PCR)检测CD40mRNA的表达水平。结果:成功构建CD40-siRNA慢病毒载体,当p LL3.7-CD40-siRNA、p MD2.G、p MDL g/p RRE和与pRSV-REV的比例为2∶1∶1∶1时,制备的慢病毒滴度最高;慢病毒感染J774.1细胞的效率呈时间依赖性,感染第8天时的感染效率最高;同时,p LL3.7-CD40-siRNA组CD40 mRNA的表达明显低于p LL3.7空载体组,差异有统计学意义(P<0.05)。结论:慢病毒感染J774.1细胞的效率可以满足后续实验的要求,CD40-siRNA慢病毒载体可以抑制CD40mRNA的表达。 Objective:To construct CD40-siRNA lentiviral vector and detect its infection efficiency on mouse macrophages cells lines(J774. 1)and the level of CD40 mRNA. Methods:An effective tar-get sequence against CD40 was designed,then CD40-siRNA lentiviral vector was constructed,identi-fied by DNA sequencing and named pLL3. 7-CD40-siRNA. pLL3. 7-CD40-siRNA were co-transfected with pMD2. G,pMDL g/p RRE and pRSV-REV into 293T cells to produce lentivirus on ratio 1:1:1:1,2:1:1:1,3:1:1:1 and 4:1:1:1 respectively by Lipofectamine LTX&Plus. Lentivirus was infected into mouse J774 . 1 macrophages cells lines and infection efficiency was measured by flow cytometry on 4^th,6^th and 8^th day respectively after infection. The expression level of CD40 mRNA was measured by real-time quantitative RT-PCR methods. Results:The CD40 siRNA lentiviral vector was successfully constructed. The result of flow cytometry showed the lentivirus titer was highest on ratio 2:1:1:1(3. 5 × 10^8 TU/mL). The infection efficiency of J774. 1 cells was increased on a time-dependent manner and the infection efficiency was highest on 8^th day. Meanwhile,the expression level of CD40 mRNA was significantly lower in pLL3. 7-CD40-siRNA group than in control group. Conclusion:The lentivi-ral vector is able to infect mouse macrophages cells lines(J774. 1)and the infection efficiency can reached the need of subsequent experiments. The CD40 siRNA lentiviral vector can suppress the ex-pression of CD40 mRNA.
出处 《贵阳医学院学报》 CAS 2015年第8期801-805,809,共6页 Journal of Guiyang Medical College
基金 国家自然科学基金项目(No.30960354)
关键词 抗原 CD40 小干扰RNA 慢病毒载体 巨噬细胞 antigens CD40 small interfering RNA lentiviral vector macrophages
  • 相关文献

参考文献3

二级参考文献25

  • 1唐昱,葛郁芝,殷勤伟.RNA干扰及其在心血管疾病诊治中的应用[J].中华心血管病杂志,2005,33(11):1058-1060. 被引量:2
  • 2CHEN Xiu-ping DU Guan-hua.Lectin-like oxidized low-density lipoprotein receptor-1:protein,ligands,expression and pathophvsiological significance[J].Chinese Medical Journal,2007(5):421-426. 被引量:34
  • 3Adams JM, Difazio LT, Rolandelli RH, et al. HIF-1 : a key mediator in hypoxia. Aeta Physiol Hung, 2009, 96( 1 ) : 19-28.
  • 4Sun HC, Qiu ZJ, Liu J, et al. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol, 2007, 30 (6) : 1359-1367.
  • 5Gillespie DL, Whang K, Ragel BT, et al. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res, 2007, 13(8) : 2441-8.
  • 6Fujiwara S, Nakagawa K, Harada H, et al. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic envi-ronment in malignant gliomas. Int J Oncol, 2007, 30 (4) : 793-802.
  • 7Cheng TL, Chang WT. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells. Methods MolBiol, 2007, 408: 223-241.
  • 8Ramezani A, Hawley RG. Overview of the HIV-Ⅰ lentiviral vector system. CurrProtoc Mol Biol, 2002,16 (21) : 1-15.
  • 9Caldwell SA, Jackson SR, Shahriari KS, et al. Nutrient sensor O- GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenie transcription factor FoxM1 [J].Oncogene, 2010, 29 (19): 2831-2842.
  • 10Kwok JM, Peck B, Monteiro LJ, et al. FOXM1 confers acquired cisplatin resistance in breast cancer cells [J]. Mol Cancer Res, 2010, 8 ( 1 ) : 24-34.

共引文献11

同被引文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部